Original Research
Published on 25 Mar 2021
Structural Basis of VSIG3: The Ligand for VISTA
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2021.625808
- 12,077 views
- 46 citations
Original Research
Published on 25 Mar 2021
in Vaccines and Molecular Therapeutics
Review
Published on 12 Oct 2021
in Alloimmunity and Transplantation